1.
Full Text
Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease
Cochrane database of systematic reviews (Online), ISSN 1469-493X, 2011, Issue 10, p. CD005305
Background Pulmonary rehabilitation has become a cornerstone in the management of patients with stable Chronic Obstructive Pulmonary Disease (COPD). Systematic...
MORTALITY | RISK-FACTORS | METAANALYSIS | MANAGEMENT | Humans | LARGE TRIALS | Randomized Controlled Trials as Topic | HOSPITALIZATION | MEDICINE, GENERAL & INTERNAL | Pulmonary Disease, Chronic Obstructive [mortality; rehabilitation] | Exercise Tolerance | Hospitalization [statistics & numerical data] | Quality of Life | PHYSICAL-ACTIVITY | QUALITY-OF-LIFE | RESPIRATORY REHABILITATION | Health Status | COPD | Pulmonary Disease, Chronic Obstructive - mortality | Pulmonary Disease, Chronic Obstructive - rehabilitation | Hospitalization - statistics & numerical data | Resistance Training - methods | Disease Progression
MORTALITY | RISK-FACTORS | METAANALYSIS | MANAGEMENT | Humans | LARGE TRIALS | Randomized Controlled Trials as Topic | HOSPITALIZATION | MEDICINE, GENERAL & INTERNAL | Pulmonary Disease, Chronic Obstructive [mortality; rehabilitation] | Exercise Tolerance | Hospitalization [statistics & numerical data] | Quality of Life | PHYSICAL-ACTIVITY | QUALITY-OF-LIFE | RESPIRATORY REHABILITATION | Health Status | COPD | Pulmonary Disease, Chronic Obstructive - mortality | Pulmonary Disease, Chronic Obstructive - rehabilitation | Hospitalization - statistics & numerical data | Resistance Training - methods | Disease Progression
Journal Article
EUROPEAN RESPIRATORY JOURNAL, ISSN 0903-1936, 09/2019, Volume 54, Issue 3
Journal Article
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, ISSN 1073-449X, 07/2019, Volume 200, Issue 1, pp. 110 - 114
[...]we aimed to examine physiological evidence of a potential restrictive pollution–lung function process and its potential modification by smoking. For the...
STANDARDIZATION | CARBON-MONOXIDE | RESPIRATORY SYSTEM | NITROGEN-DIOXIDE | CRITICAL CARE MEDICINE | Middle age | Values | Air pollution | Chronic obstructive pulmonary disease | Carbon monoxide | Pollutants | Nitrogen dioxide
STANDARDIZATION | CARBON-MONOXIDE | RESPIRATORY SYSTEM | NITROGEN-DIOXIDE | CRITICAL CARE MEDICINE | Middle age | Values | Air pollution | Chronic obstructive pulmonary disease | Carbon monoxide | Pollutants | Nitrogen dioxide
Journal Article
Thorax, ISSN 0040-6376, 07/2019, Volume 74, Issue 7, pp. 650 - 658
RationaleWhile cross-sectional studies have shown associations between certain occupational exposures and lower levels of lung function, there was little...
Journal Article
Clinical & Experimental Allergy, ISSN 0954-7894, 03/2019, Volume 49, Issue 3, pp. 331 - 340
Summary Background Markers of microbial exposure are thought to be associated with risk of allergic sensitization; however, the associations are inconsistent...
allergy | siblings | gene‐environment interaction | genetics | CD14 | allergic sensitization | gene-environment interaction | PROMOTER POLYMORPHISM | IMMUNOLOGY | GENE-ENVIRONMENT INTERACTIONS | DISEASES | ENDOTOXIN EXPOSURE | SOLUBLE CD14 | SERUM IGE LEVELS | ASTHMA | ASSOCIATION | EXPRESSION | ATOPY | Allergy | Analysis | Genes | Genetic aspects | Allergic reaction | Genetic polymorphisms | Testing | Risk reduction | Risk | Exposure | Single-nucleotide polymorphism | Regression analysis | CD14 antigen | Atopy | Microorganisms | Alleles | Skin | Children | Risk management | Age | Skin tests
allergy | siblings | gene‐environment interaction | genetics | CD14 | allergic sensitization | gene-environment interaction | PROMOTER POLYMORPHISM | IMMUNOLOGY | GENE-ENVIRONMENT INTERACTIONS | DISEASES | ENDOTOXIN EXPOSURE | SOLUBLE CD14 | SERUM IGE LEVELS | ASTHMA | ASSOCIATION | EXPRESSION | ATOPY | Allergy | Analysis | Genes | Genetic aspects | Allergic reaction | Genetic polymorphisms | Testing | Risk reduction | Risk | Exposure | Single-nucleotide polymorphism | Regression analysis | CD14 antigen | Atopy | Microorganisms | Alleles | Skin | Children | Risk management | Age | Skin tests
Journal Article
BMC Pulmonary Medicine, ISSN 1471-2466, 05/2019, Volume 19, Issue 1, p. 84
Background and objectiveGastroesophageal reflux disease (GORD) is highly prevalent in idiopathic pulmonary fibrosis (IPF) and may play a role in its...
Registry | Gastroesophageal reflux disease | Idiopathic pulmonary fibrosis | Antacid | Cough | SURVIVAL | DIAGNOSIS | PREVALENCE | MODEL | ASPIRATION | RESPIRATORY SYSTEM | IDIOPATHIC PULMONARY-FIBROSIS | DISEASE PROGRESSION | Gastroesophageal reflux | Medical research | Care and treatment | Lung diseases | Medicine, Experimental | Development and progression | Antacids
Registry | Gastroesophageal reflux disease | Idiopathic pulmonary fibrosis | Antacid | Cough | SURVIVAL | DIAGNOSIS | PREVALENCE | MODEL | ASPIRATION | RESPIRATORY SYSTEM | IDIOPATHIC PULMONARY-FIBROSIS | DISEASE PROGRESSION | Gastroesophageal reflux | Medical research | Care and treatment | Lung diseases | Medicine, Experimental | Development and progression | Antacids
Journal Article
Respirology, ISSN 1323-7799, 12/2019, Volume 24, Issue 12, pp. 1176 - 1182
ABSTRACT Background and objective Obstructive sleep apnoea (OSA) and asthma are associated, and nocturnal breathing difficulty that is usually identified as...
asthma | sleep apnoea, obstructive | bronchial hyper‐reactivity | airway resistance | sleep apnoea syndromes | Sleep disorders | Sleep | Apnea | Methacholine | Sleep apnea | Regression analysis | Asthma
asthma | sleep apnoea, obstructive | bronchial hyper‐reactivity | airway resistance | sleep apnoea syndromes | Sleep disorders | Sleep | Apnea | Methacholine | Sleep apnea | Regression analysis | Asthma
Journal Article
The Cochrane database of systematic reviews, ISSN 1469-493X, 2014, Volume 1, Issue 1, p. CD003559
Background Asthma is a respiratory (airway) condition that affects an estimated 300 million people worldwide and is associated with significant morbidity and...
Adrenal Cortex Hormones [therapeutic use] | Humans | SEVERE ALLERGIC-ASTHMA | PULMONARY-FUNCTION | SPUTUM HYALURONAN | ANTIIMMUNOGLOBULIN-E ANTIBODY | Randomized Controlled Trials as Topic | Antibodies, Monoclonal, Humanized | ADD-ON THERAPY | MEDICINE, GENERAL & INTERNAL | Antibodies, Anti-Idiotypic [therapeutic use] | Antibodies, Monoclonal [therapeutic use] | SEVERE PERSISTENT ASTHMA | DOUBLE-BLIND | Adult | HUMANIZED MONOCLONAL-ANTIBODY | QUALITY-OF-LIFE | Immunoglobulin E [blood; immunology] | ANTI-IGE ANTIBODY | Asthma [drug therapy immunology] | Chronic Disease | Child | Anti-Asthmatic Agents [therapeutic use] | Antibodies, Monoclonal, Humanized - therapeutic use | Anti-Asthmatic Agents - therapeutic use | Omalizumab | Adrenal Cortex Hormones - therapeutic use | Asthma - drug therapy | Immunoglobulin E - blood | Antibodies, Anti-Idiotypic - administration & dosage | Antibodies, Monoclonal, Humanized - administration & dosage | Immunoglobulin E - immunology | Injections, Subcutaneous | Asthma - immunology | Anti-Asthmatic Agents - administration & dosage | Antibodies, Anti-Idiotypic - therapeutic use
Adrenal Cortex Hormones [therapeutic use] | Humans | SEVERE ALLERGIC-ASTHMA | PULMONARY-FUNCTION | SPUTUM HYALURONAN | ANTIIMMUNOGLOBULIN-E ANTIBODY | Randomized Controlled Trials as Topic | Antibodies, Monoclonal, Humanized | ADD-ON THERAPY | MEDICINE, GENERAL & INTERNAL | Antibodies, Anti-Idiotypic [therapeutic use] | Antibodies, Monoclonal [therapeutic use] | SEVERE PERSISTENT ASTHMA | DOUBLE-BLIND | Adult | HUMANIZED MONOCLONAL-ANTIBODY | QUALITY-OF-LIFE | Immunoglobulin E [blood; immunology] | ANTI-IGE ANTIBODY | Asthma [drug therapy immunology] | Chronic Disease | Child | Anti-Asthmatic Agents [therapeutic use] | Antibodies, Monoclonal, Humanized - therapeutic use | Anti-Asthmatic Agents - therapeutic use | Omalizumab | Adrenal Cortex Hormones - therapeutic use | Asthma - drug therapy | Immunoglobulin E - blood | Antibodies, Anti-Idiotypic - administration & dosage | Antibodies, Monoclonal, Humanized - administration & dosage | Immunoglobulin E - immunology | Injections, Subcutaneous | Asthma - immunology | Anti-Asthmatic Agents - administration & dosage | Antibodies, Anti-Idiotypic - therapeutic use
Journal Article
Journal of Pharmaceutical and Biomedical Analysis, ISSN 0731-7085, 05/2018, Volume 154, pp. 102 - 107
Salmeterol (a long acting beta2-agonist) is a chiral molecule. (R )-salmeterol is responsible for pharmacological effect, but basic knowledge of...
Respiratory | Stereochemistry | Chiral | LABA | Asthma | CHEMISTRY, ANALYTICAL | AIRWAY | PHARMACOKINETICS | PHARMACOLOGY & PHARMACY | HYPERRESPONSIVENESS | Medical colleges | Enantiomers | Salmeterol
Respiratory | Stereochemistry | Chiral | LABA | Asthma | CHEMISTRY, ANALYTICAL | AIRWAY | PHARMACOKINETICS | PHARMACOLOGY & PHARMACY | HYPERRESPONSIVENESS | Medical colleges | Enantiomers | Salmeterol
Journal Article
Journal of Asthma, ISSN 0277-0903, 2018, pp. 1 - 8
To identify the level of non-pharmacological care received by middle-aged adults with current asthma in Australia and to identify its association with clinical...
inhaler technique | asthma action plan | Primary care | self-management | patient education
inhaler technique | asthma action plan | Primary care | self-management | patient education
Journal Article
Drug Testing and Analysis, ISSN 1942-7603, 07/2019, Volume 11, Issue 7, pp. 950 - 956
Formoterol is a long‐acting beta2‐adrenoceptor agonist (LABA) used for the treatment of asthma and exercise‐induced bronchoconstriction. Formoterol is usually...
beta2‐agonist | enantiomer | metabolism | arformoterol | SABA | CHEMISTRY, ANALYTICAL | SALBUTAMOL | ENANTIOMERS | BIOCHEMICAL RESEARCH METHODS | EXERCISE | beta2-agonist | FORMOTEROL | PHARMACOKINETICS | MUSCLE STRENGTH | PHARMACOLOGY & PHARMACY | TERBUTALINE | SKELETAL | Physiological aspects | Enantiomers | Mass spectrometry | Asthma
beta2‐agonist | enantiomer | metabolism | arformoterol | SABA | CHEMISTRY, ANALYTICAL | SALBUTAMOL | ENANTIOMERS | BIOCHEMICAL RESEARCH METHODS | EXERCISE | beta2-agonist | FORMOTEROL | PHARMACOKINETICS | MUSCLE STRENGTH | PHARMACOLOGY & PHARMACY | TERBUTALINE | SKELETAL | Physiological aspects | Enantiomers | Mass spectrometry | Asthma
Journal Article
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 06/2006, Volume 173, Issue 11, pp. 1201 - 1207
Rationale: Increased vascularity is a feature of airway remodeling in asthma with the potential to contribute to a number of functional abnormalities in this...
Blood vessels | Vascularity | Sprouting | Vascular endothelial growth factor | CELLS | PERMEABILITY FACTOR | VEGF GENE | blood vessels | BRONCHIAL-MUCOSA | vascularity | MECHANISMS | sprouting | LETHALITY | RESPIRATORY SYSTEM | vascular endothelial growth factor | INFLAMMATION | TRACHEAL MUCOSAL THICKNESS | AIRWAYS | EXPRESSION | CRITICAL CARE MEDICINE | Immunohistochemistry | Asthma - metabolism | Humans | Middle Aged | Bronchoalveolar Lavage Fluid - immunology | Vascular Endothelial Growth Factor Receptor-2 - metabolism | Male | Vascular Endothelial Growth Factor Receptor-1 - metabolism | Angiopoietin-1 - metabolism | Bronchi - blood supply | Bronchi - metabolism | Adult | Female | Vascular Endothelial Growth Factors - metabolism | Aged | Neovascularization, Pathologic - metabolism | Asthma - pathology
Blood vessels | Vascularity | Sprouting | Vascular endothelial growth factor | CELLS | PERMEABILITY FACTOR | VEGF GENE | blood vessels | BRONCHIAL-MUCOSA | vascularity | MECHANISMS | sprouting | LETHALITY | RESPIRATORY SYSTEM | vascular endothelial growth factor | INFLAMMATION | TRACHEAL MUCOSAL THICKNESS | AIRWAYS | EXPRESSION | CRITICAL CARE MEDICINE | Immunohistochemistry | Asthma - metabolism | Humans | Middle Aged | Bronchoalveolar Lavage Fluid - immunology | Vascular Endothelial Growth Factor Receptor-2 - metabolism | Male | Vascular Endothelial Growth Factor Receptor-1 - metabolism | Angiopoietin-1 - metabolism | Bronchi - blood supply | Bronchi - metabolism | Adult | Female | Vascular Endothelial Growth Factors - metabolism | Aged | Neovascularization, Pathologic - metabolism | Asthma - pathology
Journal Article
Thorax, ISSN 0040-6376, 10/2019, p. thoraxjnl-2019-213389
IntroductionAdult spirometry following community-acquired childhood pneumonia has variably been reported as showing obstructive or non-obstructive deficits. We...
Journal Article
Respirology, ISSN 1323-7799, 08/2018, Volume 23, Issue 8, pp. 780 - 787
Background and objective Chronic obstructive pulmonary disease (COPD) has potential origins in childhood but an association between childhood measles and...
interaction | asthma‐COPD overlap | childhood measles | current adult asthma | smoking | asthma-COPD overlap | STANDARDIZATION | LUNG-FUNCTION | BIRTH-WEIGHT | RESPIRATORY-TRACT INFECTION | CHILDREN | REFINED REFERENCE GROUP | RESPIRATORY SYSTEM | DISEASE | NO ASTHMA | ATOPY | Medical records | Aged | Asthma in children | Analysis | Measles | Immunization | Lung diseases | Obstructive lung disease | Chronic obstructive pulmonary disease | Children | Asthma | Smoking
interaction | asthma‐COPD overlap | childhood measles | current adult asthma | smoking | asthma-COPD overlap | STANDARDIZATION | LUNG-FUNCTION | BIRTH-WEIGHT | RESPIRATORY-TRACT INFECTION | CHILDREN | REFINED REFERENCE GROUP | RESPIRATORY SYSTEM | DISEASE | NO ASTHMA | ATOPY | Medical records | Aged | Asthma in children | Analysis | Measles | Immunization | Lung diseases | Obstructive lung disease | Chronic obstructive pulmonary disease | Children | Asthma | Smoking
Journal Article